Canada Pension Plan Investment Board’s Olema Pharmaceuticals OLMA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$144K	Buy	+11,500	New	+$154K	﹤0.01%	1639

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Canada Pension Plan Investment Board's OLMA Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 11,500 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #1639 among its holdings.

184 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Canada Pension Plan Investment Board held 11,500 shares of Olema Pharmaceuticals worth $144K as of Q2 2026.
Olema Pharmaceuticals was a new Canada Pension Plan Investment Board position in Q2 2026.
Olema Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1639 holding.
184 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.